Clene Inc
NASDAQ:CLNN
| Market Cap (Intraday) | 52.27M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.10 |
| 50-Day MA | $4.05 |
| 200-Day MA | $4.04 |
Clene Inc Stock, NASDAQ:CLNN
6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121
United States of America
Phone: +1.801.676.9695
Number of Employees: 85
Description
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.